Nebulised liposomal amphotericin B forAspergilluslung diseases: case series and literature review

Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant

(2013) Victor Monforte et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature

(2013) Ritesh Agarwal et al.   MYCOSES

Aerosolized Amphotericin B Lipid Complex as Adjunctive Treatment for Fungal Lung Infection in Patients with Cancer-Related Immunosuppression and Recipients of Hematopoietic Stem Cell Transplantation

(2013) Amar Safdar et al.   PHARMACOTHERAPY

Correlation between Triazole Treatment History and Susceptibility in Clinically Isolated Aspergillus fumigatus

(2012) Masato Tashiro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA: Figure 1–

(2012) Cendrine Godet et al.   EUROPEAN RESPIRATORY JOURNAL

Voriconazole and Posaconazole Improve Asthma Severity in Allergic Bronchopulmonary Aspergillosis and Severe Asthma with Fungal Sensitization

(2012) Livingstone Chishimba et al.   JOURNAL OF ASTHMA

Interrogation of Related Clinical Pan-Azole-Resistant Aspergillus fumigatus Strains: G138C, Y431C, and G434C Single Nucleotide Polymorphisms incyp51A, Upregulation ofcyp51A, and Integration and Activation of TransposonAtf1in thecyp51APromoter

(2011) Ahmed M. Albarrag et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High Prevalence of Azole-Resistant Aspergillus fumigatus in Adults with Cystic Fibrosis Exposed to Itraconazole

(2011) Pierre-Régis Burgel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prophylactic Application of Nebulized Liposomal Amphotericin B in Hematologic Patients with Neutropenia

(2011) Annette Hullard-Pulstinger et al.   ONKOLOGIE

Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation

(2010) Víctor Monforte et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Dose tolerability of chronically inhaled voriconazole solution in rodents

(2009) Justin A. Tolman et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety

(2009) Víctor Monforte et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Aerosolized Liposomal Amphotericin B for the Prevention of Invasive Pulmonary Aspergillosis during Prolonged Neutropenia: A Randomized, Placebo‐Controlled Trial

(2008) Bart J. Rijnders et al.   CLINICAL INFECTIOUS DISEASES

Efficiency and Safety of Inhaled Amphotericin B Lipid Complex (Abelcet) in the Prophylaxis of Invasive Fungal Infections Following Lung Transplantation

(2008) J.M. Borro et al.   TRANSPLANTATION PROCEEDINGS